These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24933348)

  • 1. Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.
    Schatzberg AF
    World J Biol Psychiatry; 2015 Jan; 16(1):2-11. PubMed ID: 24933348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
    Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
    Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPA axis genetic variation, cortisol and psychosis in major depression.
    Schatzberg AF; Keller J; Tennakoon L; Lembke A; Williams G; Kraemer FB; Sarginson JE; Lazzeroni LC; Murphy GM
    Mol Psychiatry; 2014 Feb; 19(2):220-7. PubMed ID: 24166410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
    Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition.
    Cherian K; Schatzberg AF; Keller J
    Schizophr Res; 2019 Nov; 213():72-79. PubMed ID: 31307859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A; Gomez R; Tenakoon L; Keller J; Cohen G; Williams GH; Kraemer FB; Schatzberg AF
    Psychoneuroendocrinology; 2013 Jan; 38(1):115-21. PubMed ID: 22727477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone as a therapeutic agent in psychiatry.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2013 Jun; 51(6):11-4. PubMed ID: 23814820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol circadian rhythm alterations in psychotic major depression.
    Keller J; Flores B; Gomez RG; Solvason HB; Kenna H; Williams GH; Schatzberg AF
    Biol Psychiatry; 2006 Aug; 60(3):275-81. PubMed ID: 16458262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
    Pariante CM; Miller AH
    Biol Psychiatry; 2001 Mar; 49(5):391-404. PubMed ID: 11274650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.
    Lee EE; Nieman LK; Martinez PE; Harsh VL; Rubinow DR; Schmidt PJ
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1887-96. PubMed ID: 22466349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
    Mattsson C; Reynolds RM; Simonyte K; Olsson T; Walker BR
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1347-52. PubMed ID: 19141586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.
    Pariante CM
    Ann N Y Acad Sci; 2009 Oct; 1179():144-52. PubMed ID: 19906237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study.
    Buckley T; Duggal V; Schatzberg AF
    J Clin Sleep Med; 2008 Jun; 4(3):235-41. PubMed ID: 18595436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.
    Hu P; Liu J; Zhao J; Qi XR; Qi CC; Lucassen PJ; Zhou JN
    Transl Psychiatry; 2013 Dec; 3(12):e336. PubMed ID: 24346134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
    Soria V; González-Rodríguez A; Huerta-Ramos E; Usall J; Cobo J; Bioque M; Barbero JD; García-Rizo C; Tost M; Monreal JA; ; Labad J
    Psychoneuroendocrinology; 2018 Jul; 93():8-19. PubMed ID: 29680774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression.
    Watson S; Gallagher P; Del-Estal D; Hearn A; Ferrier IN; Young AH
    Psychol Med; 2002 Aug; 32(6):1021-8. PubMed ID: 12214783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
    Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
    J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.